Löhr J Matthias, Dominguez-Munoz Enrique, Rosendahl Jonas, Besselink Marc, Mayerle Julia, Lerch Markus M, Haas Stephan, Akisik Fatih, Kartalis Nikolaos, Iglesias-Garcia Julio, Keller Jutta, Boermeester Marja, Werner Jens, Dumonceau Jean-Marc, Fockens Paul, Drewes Asbjorn, Ceyhan Gürlap, Lindkvist Björn, Drenth Joost, Ewald Nils, Hardt Philip, de Madaria Enrique, Witt Heiko, Schneider Alexander, Manfredi Riccardo, Brøndum Frøkjer J, Rudolf Sasa, Bollen Thomas, Bruno Marco
Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
United European Gastroenterol J. 2017 Mar;5(2):153-199. doi: 10.1177/2050640616684695. Epub 2017 Jan 16.
There have been substantial improvements in the management of chronic pancreatitis, leading to the publication of several national guidelines during recent years. In collaboration with United European Gastroenterology, the working group on 'Harmonizing diagnosis and treatment of chronic pancreatitis across Europe' (HaPanEU) developed these European guidelines using an evidence-based approach.
Twelve multidisciplinary review groups performed systematic literature reviews to answer 101 predefined clinical questions. Recommendations were graded using the Grading of Recommendations Assessment, Development and Evaluation system and the answers were assessed by the entire group in a Delphi process online. The review groups presented their recommendations during the 2015 annual meeting of United European Gastroenterology. At this one-day, interactive conference, relevant remarks were voiced and overall agreement on each recommendation was quantified using plenary voting (Test and Evaluation Directorate). After a final round of adjustments based on these comments, a draft version was sent out to external reviewers.
The 101 recommendations covered 12 topics related to the clinical management of chronic pancreatitis: aetiology (working party (WP)1), diagnosis of chronic pancreatitis with imaging (WP2 and WP3), diagnosis of pancreatic exocrine insufficiency (WP4), surgery in chronic pancreatitis (WP5), medical therapy (WP6), endoscopic therapy (WP7), treatment of pancreatic pseudocysts (WP8), pancreatic pain (WP9), nutrition and malnutrition (WP10), diabetes mellitus (WP11) and the natural course of the disease and quality of life (WP12). Using the Grading of Recommendations Assessment, Development and Evaluation system, 70 of the 101 (70%) recommendations were rated as 'strong' and plenary voting revealed 'strong agreement' for 99 (98%) recommendations.
The 2016 HaPanEU/United European Gastroenterology guidelines provide evidence-based recommendations concerning key aspects of the medical and surgical management of chronic pancreatitis based on current available evidence. These recommendations should serve as a reference standard for existing management of the disease and as a guide for future clinical research.
慢性胰腺炎的管理已有显著改善,近年来已有多项国家指南发布。“欧洲慢性胰腺炎诊断与治疗协调”(HaPanEU)工作组与欧洲胃肠病学联合会合作,采用循证方法制定了这些欧洲指南。
12个多学科审查小组进行了系统的文献综述,以回答101个预先确定的临床问题。使用推荐分级评估、制定和评价系统对推荐意见进行分级,并通过在线德尔菲法由整个小组对答案进行评估。审查小组在欧洲胃肠病学联合会2015年年会上提出了他们的建议。在这个为期一天的互动会议上,发表了相关意见,并通过全体会议投票(测试与评估局)对每项建议的总体一致性进行了量化。在根据这些意见进行最后一轮调整后,将草案版本发送给外部评审人员。
101项建议涵盖了与慢性胰腺炎临床管理相关的12个主题:病因(工作组(WP)1)、慢性胰腺炎的影像学诊断(WP2和WP3)、胰腺外分泌功能不全的诊断(WP4)、慢性胰腺炎的手术治疗(WP5)、药物治疗(WP6)、内镜治疗(WP7)、胰腺假性囊肿的治疗(WP8)、胰腺疼痛(WP9)、营养与营养不良(WP10)、糖尿病(WP11)以及疾病的自然病程和生活质量(WP12)。使用推荐分级评估、制定和评价系统,101项建议中的70项(70%)被评为“强烈推荐”,全体会议投票显示99项(98%)建议获得“强烈同意”。
2016年HaPanEU/欧洲胃肠病学联合会指南基于当前可得证据,为慢性胰腺炎医疗和手术管理的关键方面提供了循证建议。这些建议应作为该疾病现有管理的参考标准以及未来临床研究的指南。